Search results for "Nephron sparing surgery"

showing 8 items of 8 documents

Treatment of cT1a Renal Tumours in Germany: A Nationwide Survey.

2015

<b><i>Objective:</i></b> To identify clinical parameters influencing German urologists treating cT1a renal tumours, we performed a nationwide survey among members of the German urological associations (DGU and BDU). <b><i>Material and Methods:</i></b> In spring 2012, DGU and BDU members were invited to complete our survey. For 8 cases and 3 index patients, participants were asked about their preferred treatment. Multivariate analyses were used to identify significant parameters leading the responders to favour radical nephrectomy (RN) over nephron sparing surgery (NSS) as well as active surveillance (AS) over invasive treatment. <b><i…

AdultMalemedicine.medical_specialtyMultivariate analysismedicine.medical_treatmentBiopsyUrology030232 urology & nephrologyRenal functionNationwide surveyKidneyNephrectomy03 medical and health sciencesImpaired renal function0302 clinical medicineInternal medicineGermanySurveys and QuestionnairesBiopsymedicineHumansAgedKidneymedicine.diagnostic_testbusiness.industryNephronsMiddle AgedNephrectomyKidney NeoplasmsSurgerymedicine.anatomical_structure030220 oncology & carcinogenesisMultivariate AnalysisFemaleNephron sparing surgerybusinessTomography X-Ray ComputedUrologia internationalis
researchProduct

Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.

2007

Elective nephron sparing surgery is established as an alternative to radical nephrectomy for renal cell carcinoma if tumors are small (4 cm or less, stage T1a). We compared outcomes in patients with renal cell carcinoma 4 cm or less (small) vs more than 4 cm (large) who were treated with nephron sparing surgery.Between 1979 and 2006, 618 patients underwent elective nephron sparing surgery at our institution. Of these patients 474 (76.7%) had renal cell carcinoma, which was 4 cm or less in 372 (78.5%) and more than 4 cm in 102 (21.5%). Followup was 4.7 (range 0.1 to 23.9) years for small and 4.7 (range 0.1 to 24.1) years for large tumors. Cancer specific survival and local recurrence free su…

Adultmedicine.medical_specialtyUrologymedicine.medical_treatmentUrologyNephrectomyRenal cell carcinomaparasitic diseasesmedicineCarcinomaHumansStage (cooking)Survival rateCarcinoma Renal CellAgedRetrospective StudiesAged 80 and overKidneybusiness.industryNephronsMiddle Agedmedicine.diseaseNephrectomyKidney NeoplasmsSurgeryLog-rank testmedicine.anatomical_structureNephron sparing surgerybusinessThe Journal of urology
researchProduct

Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal V…

2014

Background: Approximately 10-20% of recurrences in patients treated with nephrectomy for renal cell carcinoma (RCC) develop beyond 5 yr after surgery (late recurrence). Objective: To determine features associated with late recurrence. Design, setting, and participants: A total of 5009 patients from a multicenter database comprising 13 107 RCC patients treated surgically had a minimum recurrence-free survival of 60 mo (median follow-up [FU]: 105 mo [range: 78-135]); at last FU, 4699 were disease free (median FU: 103 mo [range: 78-134]), and 310 patients (6.2%) experienced disease recurrence (median FU: 120 mo [range: 93-149]). Interventions: Patients underwent radical nephrectomy or nephron-…

MaleTime FactorsDatabases FactualLymphovascular invasionmedicine.medical_treatmentPredictive Value of Testcomputer.software_genreNephrectomyRisk modelDecision Support TechniqueRisk FactorsRetrospective StudieRenal cell carcinomaOdds Ratiolate recurrencenephrectomyMedicineMultivariate AnalysiFramingham Risk ScoreDatabaseKidney Neoplasmrenal carcinomaPrognostic parametersMiddle AgedNephrectomyKidney NeoplasmsTreatment OutcomeLymphatic MetastasisFemaleRadiologyNephron sparing surgeryPrognostic parameterHumanmedicine.medical_specialtyrenal cell carcinomarecurrenceLogistic ModelTime FactorUrologyReproducibility of ResultLate recurrencecancer-specific mortalityrisk scoreRisk AssessmentDisease-Free SurvivalDecision Support Techniquescancer-specific mortality; late recurrence; nephrectomy; prognostic parameters; renal cell carcinoma; risk scorePredictive Value of TestsLate RecurrenceHumansInternal validationCarcinoma Renal CellProportional Hazards ModelsRetrospective StudiesAgedNeoplasm StagingChi-Square Distributionbusiness.industryProportional hazards modelRisk Factorrenal cell carcinoma; recurrence; Cancer-specific mortality; Late recurrence; Nephrectomy; Prognostic parameters; Risk scoreCancer-specific mortalityReproducibility of ResultsLymphatic MetastasiRetrospective cohort studyOdds ratioprognostic parametersmedicine.diseaseConfidence intervalLogistic ModelsMultivariate AnalysisProportional Hazards ModelRisk scoreNeoplasm GradingNeoplasm Recurrence LocalbusinesscomputerCancer-specific mortality; Late recurrence; Nephrectomy; Prognostic parameters; Renal cell carcinoma; Risk score
researchProduct

Imperative and Elective Indications for Nephron-Sparing Surgery for Renal Tumors: Long-Term Oncological Follow-Up

2010

INTRODUCTION: Nephron-sparing surgery (NSS) is mandatory for patients with renal tumors in both kidneys or in a solitary kidney in order to preserve renal function (imperative indication). NSS has also become the gold standard (elective indication) for small unilateral renal tumors (< 4 cm) with a normal contralateral kidney. We report the oncological long-term follow-up of NSS of our own series and discuss the results of the current literature. PATIENTS AND METHODS: From 1979 until 2006, a total of 851 patients was treated at our institu-tion by NSS. The mean tumor diameter was 3 cm (0.5-11 cm) for elective cases and 4.2 cm (1.2-11 cm) for imperative cases. The median follow-up for electiv…

Reoperationmedicine.medical_specialtyUrologySolitary kidneyRenal functionNephrectomyDisease-Free SurvivalNeoplasms Multiple PrimaryPostoperative ComplicationsRenal cell carcinomamedicineHumansCarcinoma Renal CellRetrospective StudiesTumor sizebusiness.industryGold standardNephronsmedicine.diseaseKidney NeoplasmsSurgeryElective Surgical ProceduresKidney Failure ChronicChronic renal failureBoth kidneysNephron sparing surgeryNeoplasm Recurrence LocalbusinessFollow-Up StudiesAktuelle Urologie
researchProduct

Surgical treatment for renal cell carcinoma

2010

Renal cell carcinoma is chemoresistent and radio-therapy so that surgical tumour excision of the tumor is the only potentially curative option, either as radical nephrectomy or as nephron sparing surgery. As a result of continuously improving radiological imaging modalities, renal tumours are nowadays detected incidentally at an asymptomatic stage in up to 75 %. The ten-year cancer-specific survival for organ-confined disease (T1, T2) after R0-excision is > 90 %. Moreover, locally extending renal tumours (T3) can be treated successfully with five-year survival rates of > 65 %. In case of tumours in a single kidney or synchronous bilateral tumours, good functional and oncological long-term r…

Tumour excisionmedicine.medical_specialtybusiness.industryUrologymedicine.medical_treatmentUrologyMedizinRenal functionDiseaseGeneral Medicinemedicine.diseaseAsymptomaticNephrectomyRenal cell carcinomaCarcinomamedicineNephron sparing surgerymedicine.symptomStage (cooking)Surgical treatmentbusiness
researchProduct

Nephron-sparing surgery versus radical nephrectomy for kidney tumors: benefits and limitations

2011

medicine.medical_specialtyKidneybusiness.industrymedicine.medical_treatmentUrologymedicine.diseaseNephrectomymedicine.anatomical_structureOncologyRenal cell carcinomamedicinePharmacology (medical)Nephron sparing surgerybusinessExpert Review of Anticancer Therapy
researchProduct

Perioperative morbidity and renal function in young and elderly patients undergoing elective nephron-sparing surgery or radical nephrectomy for renal…

2010

Objective To analyse renal function, perioperative morbidity and overall survival (OS) in patients aged 65 years treated by radical nephrectomy (RN) or elective nephron-sparing surgery (NSS) for renal tumours > 4 cm. Patients and methods From our database, we identified 829 patients with renal tumours > 4 cm treated by either RN (n = 641) or NSS (n= 188) at our institution between 1981 and 2007. After excluding patients with imperative indication and metastases, we identified retrospectively 81 patients aged 65 years (elderly patients) treated for renal tumours > 4 cm. In all, 36 and 33 patients underwent NSS and 45 and 52 patients underwent RN in the young and elderly group, respectively. …

medicine.medical_specialtybusiness.industryUrologymedicine.medical_treatmentRenal functionPerioperativeurologic and male genital diseasesmedicine.diseaseNephrectomySurgerymedicineOverall survivalCarcinomaNephron sparing surgeryYoung adultbusinessKidney diseaseBJU International
researchProduct

UP-01.200 Oncological Long-Term Results of Elective Nephron-Sparing Surgery versus Radical Nephrectomy for Renal Tumours Larger Than 4cm

2011

medicine.medical_specialtybusiness.industryUrologymedicine.medical_treatmentUrologymedicineLong term resultsNephron sparing surgerybusinessNephrectomySurgeryUrology
researchProduct